Compile Data Set for Download or QSAR
Report error Found 192 Enz. Inhib. hit(s) with all data for entry = 7475
TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197114BDBM197114(US9216182, 1.60)
Affinity DataKi:  0.100nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197113BDBM197113(US9216182, 1.59)
Affinity DataKi:  0.200nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197117BDBM197117(US9216182, 1.63)
Affinity DataKi:  0.200nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197116BDBM197116(US9216182, 1.62)
Affinity DataKi:  0.200nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197092BDBM197092(US9216182, 1.38)
Affinity DataKi:  0.300nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197132BDBM197132(US9216182, 1.78)
Affinity DataKi:  0.300nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197118BDBM197118(US9216182, 1.64)
Affinity DataKi:  0.300nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197128BDBM197128(US9216182, 1.74)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197115BDBM197115(US9216182, 1.61)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197127BDBM197127(US9216182, 1.73)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197073BDBM197073(US9216182, 1.19)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197121BDBM197121(US9216182, 1.67)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197104BDBM197104(US9216182, 1.50)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197106BDBM197106(US9216182, 1.52)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197087BDBM197087(US9216182, 1.33)
Affinity DataKi:  0.400nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197125BDBM197125(US9216182, 1.71)
Affinity DataKi:  0.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197110BDBM197110(US9216182, 1.56)
Affinity DataKi:  0.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197091BDBM197091(US9216182, 1.37)
Affinity DataKi:  0.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197112BDBM197112(US9216182, 1.58)
Affinity DataKi:  0.600nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197097BDBM197097(US9216182, 1.43)
Affinity DataKi:  0.700nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197108BDBM197108(US9216182, 1.54)
Affinity DataKi:  0.700nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197111BDBM197111(US9216182, 1.57)
Affinity DataKi:  0.700nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197102BDBM197102(US9216182, 1.48)
Affinity DataKi:  0.900nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197103BDBM197103(US9216182, 1.49)
Affinity DataKi:  1nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197146BDBM197146(US9216182, 1.92)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197130BDBM197130(US9216182, 1.76)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197076BDBM197076(US9216182, 1.22 | US9216182, 1.23)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197124BDBM197124(US9216182, 1.70)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197120BDBM197120(US9216182, 1.66)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197123BDBM197123(US9216182, 1.69)
Affinity DataKi:  1.10nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197114BDBM197114(US9216182, 1.60)
Affinity DataKi:  1.40nMpH: 7.5Assay Description:The affinity of compounds of the invention to the H3 receptor can be assessed by measuring displacement of binding of the radioligand [3H]-N- ±-Methy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197105BDBM197105(US9216182, 1.51)
Affinity DataKi:  1.40nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197056BDBM197056(US9216182, 1.2)
Affinity DataKi:  1.40nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197131BDBM197131(US9216182, 1.77)
Affinity DataKi:  1.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197140BDBM197140(US9216182, 1.86)
Affinity DataKi:  1.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197063BDBM197063(US9216182, 1.9)
Affinity DataKi:  1.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197062BDBM197062(US9216182, 1.8)
Affinity DataKi:  1.5nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197083BDBM197083(US9216182, 1.29)
Affinity DataKi:  1.60nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197076BDBM197076(US9216182, 1.22 | US9216182, 1.23)
Affinity DataKi:  1.60nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197109BDBM197109(US9216182, 1.55)
Affinity DataKi:  1.60nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197107BDBM197107(US9216182, 1.53)
Affinity DataKi:  1.60nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197096BDBM197096(US9216182, 1.42)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197079BDBM197079(US9216182, 1.25)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197078BDBM197078(US9216182, 1.24)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197094BDBM197094(US9216182, 1.40)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197126BDBM197126(US9216182, 1.72)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197057BDBM197057(US9216182, 1.3)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197088BDBM197088(US9216182, 1.34)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197122BDBM197122(US9216182, 1.68)
Affinity DataKi:  1.70nMAssay Description:The potency of compounds of the invention as H3 receptor antagonists can be assessed by measuring the blockade of (R)-alpha-methylhistamine-mediated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

TargetHistamine H3 receptor(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 197128BDBM197128(US9216182, 1.74)
Affinity DataKi:  1.80nMpH: 7.5Assay Description:The affinity of compounds of the invention to the H3 receptor can be assessed by measuring displacement of binding of the radioligand [3H]-N- ±-Methy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/18/2016
Entry Details
US Patent

Displayed 1 to 50 (of 192 total ) | Next | Last >>
Jump to: